A Democratic bill with 15 Democratic cosponsors · See all 15 cosponsors
Last activity — Referred to the Committee on Veterans' Affairs, and in addition to the Committee on Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill, known as the "MISSION Rx Act," seeks to amend titles 10 and 38 of the United States Code. It aims to set maximum cost-sharing amounts for eligible beneficiaries under the TRICARE program and for veterans regarding selected drugs. The legislation aligns these costs with the Medicare Drug Price Negotiation Program established under the Social Security Act. Additionally, it establishes limits on the prices of drugs procured by Federal agencies. The bill ensures that drug manufacturers cannot exceed the maximum fair price set by the Drug Price Negotiation Program in their master agreements.
Yes· 3 of 6
- Scored +8
Does this lower the price of prescription medicines?
The bill caps cost-sharing for TRICARE beneficiaries, veterans, and Federal agency procurements based on negotiated Medicare prices.
- Scored +7
Would veterans be better off under this, taking everything together?
The bill specifically lowers copayments for veterans seeking selected drugs.
- Scored +7
Does this increase the pay, pensions or support veterans receive?
The bill reduces copayments for selected drugs for veterans by aligning them with Medicare negotiation prices.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Lower Costs for TRICARE Beneficiaries: The bill limits the cost-sharing amount for a selected drug to not exceed the amount paid by a Medicare beneficiary under the Drug Price Negotiation Program. This is found in Section 2(a).
-
Lower Costs for Veterans: The bill limits the copayment amount for a selected drug for a veteran so that it does not exceed the copocation amount paid by a Medicare beneficiary under the Drug Price Negotiation Program. This is found in Section 2(b).
-
Price Control on Federal Procurement: The bill prevents manufacturers from setting the maximum price for a selected drug in a master agreement at a price exceeding the maximum fair price set by the Drug Price Negotiation Program. This is found in Section 2(c).
Potential Negative Impacts for People
- Price Adjustments upon Program Termination: If the Drug Price Negotiation Program is terminated, master agreements must be modified to reflect drug price maximums under existing law. This is found in Section 2(d)(2).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Demographic And Interest Groups
- Would veterans be better off under this, taking everything together? — The bill specifically lowers copayments for veterans seeking selected drugs. Would people over 65 be better off under this? — The bill utilizes the Medicare Drug Price Negotiation Program which primarily benefits the senior population. Would households on low incomes be better off under this? — Lowering drug costs provides financial relief to low-income households.
- Healthcare
- Does this lower the price of prescription medicines? — The bill caps cost-sharing for TRICARE beneficiaries, veterans, and Federal agency procurements based on negotiated Medicare prices.
- National Security And Foreign Policy
- Does this increase the pay, pensions or support veterans receive? — The bill reduces copayments for selected drugs for veterans by aligning them with Medicare negotiation prices.
- Economy And Finance
- Does this reduce what the federal government spends? — The bill limits the price of drugs procured by Federal agencies by aligning them with the Drug Price Negotiation Program.
- 7/21/2026
- 1 Cosponsor added.
- 6/23/2026
- 1 Cosponsor added.
- 6/15/2026
- 1 Cosponsor added.
- 5/13/2026
- 2 Cosponsors added.
- 5/12/2026
- 2 Cosponsors added.
- 5/11/2026
- 2 Cosponsors added.
- 5/7/2026
- Referred to the Committee on Veterans' Affairs, and in addition to the Committee on Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 6 Cosponsors added.
- Introduced in House
Nikki BudzinskiDemocrat · Illinois
André CarsonDemocrat · Indiana
Christopher DeluzioDemocrat · Pennsylvania
Sharice DavidsDemocrat · Kansas
Maggie GoodlanderDemocrat · New Hampshire
Adelita GrijalvaDemocrat · Arizona
Chrissy HoulahanDemocrat · Pennsylvania
William KeatingDemocrat · Massachusetts
Ro KhannaDemocrat · California
Rick LarsenDemocrat · Washington
Seth MoultonDemocrat · Massachusetts
Eleanor NortonDemocrat · District of Columbia
Mike QuigleyDemocrat · Illinois
Patrick RyanDemocrat · New York
Melanie StansburyDemocrat · New Mexico